400 related articles for article (PubMed ID: 25092158)
1. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
2. (1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer.
Chan AW; Mercier P; Schiller D; Bailey R; Robbins S; Eurich DT; Sawyer MB; Broadhurst D
Br J Cancer; 2016 Jan; 114(1):59-62. PubMed ID: 26645240
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
5. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
6. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
7. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer.
Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA
Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
9. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
[TBL] [Abstract][Full Text] [Related]
10. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
11. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
12. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
Hui L; Rixv L; Xiuying Z
Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
[TBL] [Abstract][Full Text] [Related]
13. Assessing Exposome Effects on Pregnancy through Urine Metabolomics of a Portuguese (Estarreja) Cohort.
Gil AM; Duarte D; Pinto J; Barros AS
J Proteome Res; 2018 Mar; 17(3):1278-1289. PubMed ID: 29424227
[TBL] [Abstract][Full Text] [Related]
14. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
15. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
16. Targeted Metabolomic Profiling of Plasma Samples in Gastric Cancer by Liquid Chromatography-Mass Spectrometry.
Matsumoto T; Fukuzawa M; Itoi T; Sugimoto M; Aizawa Y; Sunamura M; Kawai T; Nemoto D; Shinohara H; Muramatsu T; Suzuki Y; Kagawa Y; Suguro M; Uchida K; Koyama Y; Madarame A; Morise T; Yamaguchi H; Sugimoto A; Yamauchi Y; Kono S; Naito S
Digestion; 2023; 104(2):97-108. PubMed ID: 36404717
[TBL] [Abstract][Full Text] [Related]
17. ¹H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure.
Kang SM; Park JC; Shin MJ; Lee H; Oh J; Ryu DH; Hwang GS; Chung JH
Clin Biochem; 2011 Mar; 44(4):293-9. PubMed ID: 21167146
[TBL] [Abstract][Full Text] [Related]
18. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
[TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
20. A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis.
Chen Y; Zhang J; Guo L; Liu L; Wen J; Xu L; Yan M; Li Z; Zhang X; Nan P; Jiang J; Ji J; Zhang J; Cai W; Zhuang H; Wang Y; Zhu Z; Yu Y
Oncotarget; 2016 Dec; 7(52):87496-87510. PubMed ID: 27589838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
